Clinical trial
Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
NCT00141999 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00141999 |
|---|---|
| Title | Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents |
| Official title | An Evaluation of Long-Term Protection Against Hepatitis B Virus Infection: Response of Alaska Native Children and Adolescents Who Received the Primary Recombinant Hepatitis B Vaccine Series Beginning at Birth to an Additional Dose of Vaccine |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Alaska Native Medical Center |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis |
| Intervention type | Biological |
| Interventions | hepatitis B vaccine |
| Enrollment | 400 |
| Start date | May 1, 2001 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2008 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: